Intratumoral immunotherapy is one of the most recent scientific advances for cancer treatments. This discovery has had some amazing results, including eliminating traces of cancer cells within the patient’s body.
This treatment is centered around the idea of using the tumor as the vaccine to fight against cancer. It entails directly injecting high concentrations of immunostimulatory products, coupled with a small amount of medication, into the tumor.
One study published in the journal The Oncologist has shown that the overall response rate of this treatment was 55 percent, in a treatment course done over 12 weeks. Those who underwent a second course had a 26% to 51% success rate.
Here are five benefits to intratumoral immunotherapy: